- Article
5 Citations
786 Views
4 Pages
The Politicization of Oncology Drug Funding Reviews in Canada
- C. Skedgel and
- T. Younis
An article in this issue by Srikanthan, [...]
- 3.4Impact Factor
- 4.9CiteScore
- 22 daysTime to First Decision
- Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Current Oncology, Volume 23, Issue 3
June 2016 - 31 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (31)
- Article
15 Citations
1,012 Views
10 Pages
Palliative Chemotherapy in Advanced Colorectal Cancer Patients 80 Years of Age and Older
- P. Lai,
- S. Sud,
- T. Zhang,
- T. Asmis and
- P. Wheatley-Price
Background: Colorectal cancer (crc) has a median diagnostic age of 68 years. Despite significant progress in chemotherapy (ctx) options, few data on outcomes or toxicity from ctx in patients 80 years of age and older are available. We investigated ct...
- Article
3 Citations
666 Views
10 Pages
Provincial Elections and Timing of Cancer Drug Funding
- A. Srikanthan,
- S.S. Gill and
- K.K.W. Chan
Background: Concerns have been raised about the potential influence of political pressures on drug funding decisions. We evaluated the temporal relationship between cancer drug funding and provincial elections in 9 Canadian provinces. Methods: New in...
- Article
8 Citations
1,371 Views
7 Pages
Retrospective Analysis of the Effect of CAPOX and mFOLFOX6 Dose Intensity on Survival in Colorectal Patients in the Adjuvant Setting
- A. Mamo,
- J. Easaw,
- F. Ibnshamsah,
- A. Baig,
- Y.S. Rho,
- T. Kavan,
- G. Batist and
- P. Kavan
Background: Despite lack of a true comparative study, the folfox (5-fluorouracil–leucovorin–oxaliplatin) and capox (capecitabine–oxaliplatin) regimens are believed to be similar in their efficacy and tolerability in the treatment of stage III colorec...
- Article
5 Citations
918 Views
6 Pages
Approach to Biomarker Testing: Perspectives from Various Specialties
- M.R. Sung,
- P.M. Ellis,
- S. Verma,
- E. Duncan and
- N.B. Leighl
Background: Despite its importance for patient outcomes, biomarker testing for lung cancer is not uniformly integrated into the Canadian health care system. To better understand current practice patterns for lung cancer biomarker testing, we assessed...
- Article
30 Citations
1,546 Views
12 Pages
Management of Small-Cell Lung Cancer with Radiotherapy—A Pan-Canadian Survey of Radiation Oncologists
- J. Shahi,
- J.R. Wright,
- Z. Gabos and
- A. Swaminath
Background: The management of small-cell lung cancer (SCLC) with radiotherapy (RT) varies, with many treatment regimens having been described in the literature. We created a survey to assess patterns of practice and clinical decision-making in the ma...
- Article
13 Citations
1,157 Views
5 Pages
Canadian Consensus: Inhibition of Alk-Positive Tumours in Advanced Non-Small-Cell Lung Cancer
- B. Melosky,
- J. Agulnik,
- R. Albadine,
- S. Banerji,
- D.G. Bebb,
- D. Bethune,
- N. Blais,
- C. Butts,
- P. Cheema and
- P. Cheung
- + 11 authors
Anaplastic lymphoma kinase (alk) is an oncogenic driver in non-small-cell lung cancer (nsclc). Chromosomal rearrangements involving the ALK gene occur in up to 4% of nonsquamous nsclc patients and lead to constitutive activation of the alk signalling...
- Article
8 Citations
1,279 Views
3 Pages
Smoking Behaviours of Current Cancer Patients in Canada
- J. Liu,
- J. Chadder,
- S. Fung,
- G. Lockwood,
- R. Rahal,
- M. Halligan,
- D. Mowat and
- H. Bryant
Evidence shows that continued smoking by cancer patients leads to adverse treatment outcomes and affects survival. Smoking diminishes treatment effectiveness, exacerbates side effects, and increases the risk of developing additional complications. Pa...
- Short Communication
23 Citations
1,364 Views
6 Pages
Adolescent and Young Adult Cancer: Principles of Care
- R. Ramphal,
- S. Aubin,
- P. Czaykowski,
- S. De Pauw,
- A. Johnson,
- S. McKillop,
- D. Szwajcer,
- K. Wilkins and
- P. Rogers
Adolescents and young adults (AYAS) with cancer in active treatment face a number of barriers to optimal care. In the present article, we focus on the 3 critical domains of care for ayas—medical, psychosocial, and research—and how changes to the syst...
- Article
690 Views
3 Pages
The Canadian Lung Cancer Conference 2016
- B. Melosky and
- C. Ho
Each February, the Canadian Lung Cancer Conference brings together lung cancer researchers, clinicians, and care professionals who are united in their commitment to improve the care of patients with lung cancer. This year’s meeting, held 11–12 Februa...
of 4